IM Cannabis (IMCC) Short-term Investments (2019 - 2025)
IM Cannabis' (IMCC) quarterly Short-term Investments came in at $1.3 million in Q4 2025, up 9.08% year-on-year from $1.2 million in Q4 2024, and up 54.56% quarter-over-quarter from $824004.1 in Q3 2025.
IM Cannabis (IMCC) Short-term Investments (2019 - 2025) Analysis & Trends
IM Cannabis' Short-term Investments history runs 7 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- On a quarterly basis, Short-term Investments rose 9.08% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 9.08% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 6.91% from the prior year.
- Short-term Investments grew to $1.3 million in Q4 2025 per IMCC's latest filing, from $824004.1 in the prior quarter.
- Across five years, Short-term Investments topped out at $5.4 million in Q1 2021 and bottomed at $11106.7 in Q4 2021.
- The 5-year median for Short-term Investments is $1.4 million (2025), against an average of $1.7 million.
- Biggest YoY gain for Short-term Investments was 15885.43% in 2022; the steepest drop was 74.88% in 2022.
- Year by year, Short-term Investments stood at $11106.7 in 2021, then jumped by 15885.43% to $1.8 million in 2022, then decreased by 5.47% to $1.7 million in 2023, then plunged by 30.44% to $1.2 million in 2024, then gained by 9.08% to $1.3 million in 2025.
- Per Business Quant, the three latest IMCC Short-term Investments figures stand at $1.3 million (Q4 2025), $824004.1 (Q3 2025), and $1.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 824,004.09 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 576,138.75 |
| Mar 31, 2024 | 578,848.30 |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 893,624.70 |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 652,501.05 |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 11,106.71 |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 5.39 Mn |
| Dec 31, 2020 | -1.03 Mn |
| Jun 30, 2020 | -197,609.88 |